Working together : the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D

Child, H. W. and del Pino, P. A. and De la Fuente, J. M. and Hursthouse, A. S. and Stirling, D. and Mullen, M. and McPhee, G. M. and Nixon, C. and Jayawarna, V. and Berry, C. C. (2011) Working together : the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D. ACS Nano, 5 (10). pp. 7910-7919. ISSN 1936-0851 (https://doi.org/10.1021/nn202163v)

Full text not available in this repository.Request a copy

Abstract

Nanoparticles (NPs) are currently being developed as vehicles for in vivo drug delivery. Two of the biggest barriers facing this therapy are the site-specific targeting and consequent cellular uptake of drug-loaded NPs1. In vitro studies in 2D cell cultures have shown that an external magnetic field (MF) and functionalization with cell-penetrating peptides (CPPs) have the capacity to overcome these barriers. This study aimed to investigate if the potential of these techniques, which has been reported in 2D, can be successfully applied to cells growing in a 3D environment. As such, this study provides a more realistic assessment of how these techniques might perform in future clinical settings. The effect of a MF and/or penetratin attachment on the uptake of 100 and 200 nm fluorescent iron oxide magnetic NPs (mNPs) into a fibroblast-seeded 3D collagen gel was quantified by inductively coupled plasma mass spectrometry. The most suitable mNP species was further investigated by fluorescence microscopy, histology, confocal microscopy, and TEM. Results show that gel mNP uptake occurred on average twice as fast in the presence of a MF and up to three times faster with penetratin attachment. In addition, a MF increased the distance of mNP travel through the gel, while penetratin increased mNP cell localization. This work is one of the first to demonstrate that MFs and CPPs can be effectively translated for use in 3D systems and, if applied together, will make excellent partners to achieve therapeutic drug delivery in vivo.

ORCID iDs

Child, H. W., del Pino, P. A., De la Fuente, J. M., Hursthouse, A. S., Stirling, D., Mullen, M., McPhee, G. M., Nixon, C., Jayawarna, V. ORCID logoORCID: https://orcid.org/0000-0002-2936-6634 and Berry, C. C.;